cat
vaccin
intranas
ln
temperatur
sensit
felin
infecti
periton
viru
tsfip
v
vaccin
protect
fipinducng
challeng
seventeen
vaccin
cat
surviv
rigor
virul
fip
v
challeng
caus
fip
nonvaccin
cat
die
intranas
vaccin
stimul
serum
igg
serum
salivari
iga
antibodi
respons
measur
elisa
fipvneutr
antibodi
vn
cellmedi
immun
cmi
respons
measur
lymphocyt
prolifer
serum
antibodi
respons
vaccin
associ
protect
fact
igg
iga
vn
titr
much
higher
control
cat
vaccin
cat
follow
challeng
suggest
immunemedi
pathogenesi
contrast
stimul
mucos
iga
respons
vaccin
relat
protect
vitro
prolifer
peripher
blood
lymphocyt
respons
virul
fipv
observ
vaccin
cat
vaccin
challeng
cat
nonvaccin
challeng
cat
felin
infecti
periton
viru
fipv
coronaviru
relat
transmiss
gastroenter
viru
tgev
pig
enter
coronaviru
dog
respiratori
coronaviru
man
also
felin
enter
coronaviru
fecv
antigen
relat
fipv
replic
mainli
intestin
caus
mild
diarrheal
diseas
natur
rout
fipv
infect
unknown
although
cat
experiment
infect
upon
oral
nasal
intratrach
inocul
fipv
fipv
multipli
first
epitheli
cell
upper
respiratori
tract
intestin
follow
rout
infect
clinic
appar
fip
occur
viru
cross
mucos
barrier
spread
throughout
cat
infect
macrophag
monocyt
primari
fip
may
mild
consist
febril
respons
slight
nasal
ocular
discharg
secondari
fip
may
develop
follow
primari
infect
appear
two
form
exud
wet
form
character
periton
pleuriti
ascit
pleural
effus
dri
form
character
granulomat
inflamm
differ
organ
littl
exud
form
may
appear
togeth
cat
may
becom
anem
neutrophilia
may
occur
increas
concentr
immunoglobulin
well
fibrinogen
found
case
increas
urea
creatinin
indic
renal
damag
dissemin
intravascular
coagul
also
occur
immun
pathogenesi
fip
may
postul
fipv
express
surfac
infect
cell
includ
macrophag
stimul
thelper
lymphocyt
blymphocyt
produc
virusspecif
antibodi
circul
antibodi
enhanc
infect
macrophag
may
increas
synthesi
releas
complement
antifipv
antibodi
fipv
immun
complex
could
activ
complement
cascad
caus
releas
anaphylatoxin
result
cytolysi
die
macrophag
may
releas
viru
turn
could
infect
macrophag
phagocyt
immun
complex
previou
attempt
protect
immun
fip
success
inde
immun
often
led
sever
diseas
symptom
show
report
intrans
administr
temperatur
sensit
ts
fipv
vaccin
abil
grow
temperatur
present
nasopharynx
inabl
grow
temperatur
present
parenter
protect
cat
fipv
infect
subsequ
fipvinduc
immunemedi
patholog
origin
fip
viru
isol
upon
postmortem
examin
cat
adapt
tissu
cultur
norden
laboratori
felin
kidney
nlfk
cell
line
norden
laboratori
lincoln
ne
usa
virul
strain
attenu
passag
nlfk
cell
passag
passag
propag
passag
made
temperatur
sensit
exposur
ultraviolet
uv
irradi
tsfipv
use
vaccin
cat
plaqu
purifi
propag
nlfk
cell
eight
passag
lyophil
characterist
tsfip
vaccin
viru
describ
christianson
et
al
briefli
tsfipv
unlik
virul
parent
propag
permiss
temperatur
virul
wtfipv
passag
dilut
give
challeng
titr
equal
tcidso
per
ml
optim
dilut
challeng
determin
minimum
lethal
dose
studi
cat
one
ml
viru
dilut
given
oral
score
system
devis
judg
extent
diseas
shown
tabl
igg
iga
serum
antibodi
titr
determin
elisa
elisa
antigen
prepar
differenti
centrifug
clarifi
fluid
antigen
dilut
optimum
concentr
sodium
tetrabor
ph
ad
well
microtitr
plate
nunc
roskild
denmark
adsorpt
overnight
well
empti
solut
polyvinyl
alcohol
protect
felin
infecti
periton
jd
gerber
et
al
phosphat
buffer
salin
pva
ph
ad
allow
incub
h
solut
decant
serum
dilut
fetal
bovin
serum
fb
ad
duplic
well
known
posit
serum
known
neg
serum
place
plate
control
incub
plate
decant
wash
three
time
pbstween
ph
volum
dilut
goat
anticat
igg
horseradish
peroxidas
kirkegaardperri
gaithersburg
md
usa
pbsfb
ad
well
allow
incub
min
content
plate
discard
wash
three
time
pbstween
sulphon
abt
substrat
kirkegaardperri
gaithersburg
md
usa
ad
well
plate
read
spectrophotometr
microelisa
reader
molecular
devic
palo
alto
ca
usa
dual
wavelength
titr
report
reciproc
highest
dilut
gave
absorb
read
wia
posit
control
min
addit
substrat
iga
elisa
titr
obtain
way
igg
elisa
titr
except
goat
anticat
iga
nordic
immunolog
lab
toro
ca
usa
rabbit
antigoat
igg
horseradish
peroxidas
use
saliva
collect
cotton
swab
place
diluent
contain
pva
fb
flmercaptoethanol
thimerosol
pb
ph
h
swab
remov
diluent
centrifug
supernat
remov
frozen
elisa
method
describ
serum
iga
elisa
absorb
read
serum
iga
posit
control
reach
absorb
read
approxim
increas
specif
iga
saliva
vaccin
challeng
express
iga
respons
index
igari
igari
determin
follow
absorbancedayxabsorbanceday
x
indic
day
post
first
vaccin
vnt
modif
procedur
describ
ingersol
wyli
heatinactiv
serum
sampl
dilut
twofold
medium
follow
addit
equal
volum
wtfipv
tcidsowel
incub
h
x
nlfk
cell
ad
well
plate
incub
day
humidifi
incub
enrich
test
posit
serum
neg
serum
titrat
control
viru
titrat
ensur
infect
viru
particl
per
well
use
titr
express
reciproc
highest
dilut
serum
inhibit
viral
propag
lymphocyt
prolifer
assay
use
determin
cellmedi
immun
cmi
respons
cat
wtfipv
peripher
blood
lymphocyt
pbl
purifi
manner
describ
tompkin
et
al
specif
pathogenfre
spf
cat
month
age
free
serum
anticoronaviru
antibodi
obtain
liberti
lab
liberti
n
j
usa
challeng
cat
hous
isol
cage
two
catscag
time
challeng
cat
place
nonisol
cage
four
five
catscag
cat
vaccin
twice
day
cat
differ
experi
challeng
either
day
post
second
vaccin
challeng
vaccin
control
cat
monitor
diseas
symptom
surviv
vaccin
cat
two
experi
challeng
second
time
determin
might
suscept
naiv
control
cat
second
challeng
mannwhitney
u
test
use
determin
statist
signific
differ
median
clinic
score
two
popul
distribut
statist
signific
differ
tabl
immunogen
test
group
mean
lymphocyt
blastogenesi
data
determin
use
student
test
list
three
immunogen
test
refer
paper
given
figur
also
repres
two
challeng
immun
experi
present
paper
cat
vaccin
twice
tsfipv
protect
two
oral
challeng
wtfipv
clinic
score
control
cat
follow
first
challeng
significantli
higher
vaccin
cat
p
seventeen
vaccin
cat
surviv
wtfipv
challeng
caus
fip
control
cat
ten
die
two
control
cat
die
sever
fip
symptom
euthan
addit
three
vaccin
cat
die
three
vaccin
cata
show
transient
symptom
fip
challeng
one
febril
respons
decreas
pcv
anoth
lymphopenia
shown
figur
figur
contrast
viru
neutral
antibodi
respons
peplom
antigen
elisa
titr
repres
entir
repertoir
igg
iga
antibodi
wtfipv
epitop
sinc
whole
purifi
wtfipv
use
solid
phase
antigen
first
dose
vaccin
stimul
product
igg
antibodi
increas
slightli
follow
second
vaccin
gmt
day
postchalleng
gmt
increas
drop
day
postchalleng
control
cat
tend
develop
higher
antifipv
antibodi
titr
vaccin
cat
postchalleng
gmt
control
cat
day
postchalleng
respect
low
level
serum
iga
antibodi
stimul
vaccin
figur
geometr
mean
titr
day
day
postchalleng
like
igg
elisa
titr
serum
iga
titr
vaccin
cat
increas
moder
follow
challeng
gmt
day
postchalleng
respect
iga
titr
control
cat
higher
day
day
follow
challeng
second
immunogen
studi
tabl
specif
iga
saliva
follow
vaccin
relat
protect
figur
increas
specif
iga
saliva
five
vaccin
cat
surviv
challeng
lga
level
saliva
greater
iga
level
saliva
control
cat
contrast
increas
specif
iga
saliva
vaccin
cat
surviv
challeng
specif
iga
level
saliva
increas
protect
nonprotect
vaccin
cat
control
cat
follow
challeng
increas
greater
vaccin
cat
indic
iga
memori
respons
unlik
serum
iga
igg
level
protect
vaccin
cat
declin
follow
challeng
level
iga
saliva
vaccin
cat
remain
high
follow
challeng
lga
level
saliva
vaccin
cat
increas
second
virul
wtfipv
challeng
data
shown
one
vaccin
cat
surviv
first
challeng
surviv
second
challeng
kill
five
six
naiv
control
cat
serum
iga
igg
vn
respons
vaccin
control
cat
similar
respons
cat
previou
immunogen
test
data
shown
shown
third
immunogen
test
tabl
vaccin
stimul
cmi
respons
vaccin
induc
specif
lymphocyt
prolif
respons
wtfipv
ten
cat
still
detect
day
postvaccin
tabl
day
postchalleng
prolif
respons
vaccin
cat
increas
averag
tenfold
prechalleng
level
significantli
higher
control
cat
p
effect
fipv
vaccin
stimul
strong
mucos
immun
respons
stop
system
spread
virul
fipv
cmi
respons
immedi
halt
spread
viru
cross
mucosa
stimul
nasal
mucos
immun
respons
best
done
administr
vaccin
mucos
blymphocyt
stimul
vaccin
secret
antifipv
iga
antibodi
migrat
gut
mucosa
also
confer
local
gut
immun
tsfipv
given
abil
grow
temperatur
present
nasopharyng
region
stimul
local
immun
respons
indic
iga
antibodi
saliva
addit
tsfipv
vaccin
stimul
cmi
respons
fipv
follow
two
vaccin
cmi
respons
still
detect
day
postvaccin
amplifi
follow
challeng
cmi
respons
fipv
occur
nonvaccin
cat
infect
virul
fipv
humor
immun
report
enhanc
rather
protect
experiment
fipv
infect
studi
suggest
humor
respons
fipv
per
se
detriment
tsfipv
vaccin
cat
develop
igg
iga
viru
neutral
antibodi
titr
without
cat
sensit
fipv
howev
note
geometr
mean
vn
titr
vaccin
cat
less
geometr
mean
titr
nonvaccin
control
cat
follow
challeng
high
level
vn
antibodi
peplom
epitop
may
play
signific
role
pathogenesi
diseas
inde
vennema
et
al
report
immun
respons
peplom
epitop
may
relat
diseas
found
cat
vaccin
recombin
peplom
vaccin
develop
fip
die
sooner
nonvaccin
control
cat
although
stimul
thehumor
immun
respons
often
associ
diseas
high
serum
antibodi
titr
sometim
use
aid
diagnos
fip
stimul
mucos
immun
system
indic
specif
iga
saliva
relat
protect
second
challeng
immun
studi
vaccin
cat
surviv
challeng
develop
iga
respons
wtfipv
follow
vaccin
contrast
postvaccin
level
iga
saliva
nonprotect
vaccin
cat
differ
mean
iga
level
saliva
ten
control
cat
eight
die
specif
iga
level
saliva
protect
vaccin
cat
increas
postchalleng
level
iga
saliva
three
five
nonprotect
vaccin
cat
also
increas
follow
challeng
howev
increas
level
local
iga
may
either
develop
late
prevent
infect
may
low
challeng
inhibit
spread
virul
fipv
also
possibl
cat
develop
cmi
respons
fipv
conjunct
mucos
immun
respons
necessari
protect
fip
cellmedi
immun
respons
fipv
import
especi
fipv
evad
mucos
defenc
system
pedersen
floyd
show
fipv
stimul
lymphocyt
prolifer
respons
cat
recov
fipv
infect
seroneg
uninfect
cat
stoddart
et
al
also
report
cat
surviv
fipv
challeng
develop
lymphocyt
prolifer
respons
fipv
stronger
lymphocyt
prolifer
respons
longer
cat
surviv
contrast
cat
die
day
postchalleng
develop
respons
protect
felin
infecti
periton
jd
gerber
et
al
fipv
present
studi
show
two
vaccin
tsfipv
vaccin
stimul
lymphocyt
prolifer
respons
fipv
still
detect
day
postvaccin
peripher
blood
lymphocyt
respons
wtfipv
follow
challeng
correl
abil
cat
surviv
fipv
infect
lymphocyt
prolifer
respons
vaccin
cat
increas
averag
tenfold
day
postchalleng
indic
vaccin
stimul
immun
memori
cell
respons
although
none
three
control
cat
die
develop
prolif
respons
wtfipv
postchalleng
one
two
control
cat
recov
exhibit
sign
fip
show
weak
lymphocyt
prolif
respons
day
postchalleng
sinc
lymphocyt
prolifer
assay
measur
abil
oflymphocyt
respond
fipv
natur
respons
studi
cellmedi
respons
fipv
need
done
parenterallyvaccin
cat
report
other
develop
fip
earlier
nonvaccin
cat
follow
challeng
contrast
parenter
administ
vaccin
administ
tsfipv
vaccin
predispos
vaccin
cat
fip
rout
administr
characterist
tsfipv
includ
inabl
vaccin
viru
replic
outsid
nasalpharyng
area
absenc
tsfipv
structur
protein
surfac
infect
cell
thought
reason
vaccineinduc
hypersensit
occur
summari
tsfipv
vaccin
administ
stimul
mucos
immun
respons
wtfipv
correl
immun
two
rigor
challeng
addit
administ
vaccin
stimul
long
last
cmi
respons
measur
lymphocyt
prolifer
wtfipv
